Single-cell RNA sequencing, named Nature's Method of the Year in 2013, now has over 1,000 dedicated software tools catalogued in the scRNA-tools database, and deep learning is increasingly central to how researchers make sense of the data. The core data structure is a matrix: rows are individual cells tagged with unique barcodes, columns are genes, and the values are RNA expression counts per gene per cell. The human genome spans 3 billion base pairs but only about 20,000 to 25,000 genes do the protein-coding work, roughly 1% of the total. Sequencing that 1% at single-cell resolution, rather than averaging across bulk tissue, is what makes this technology consequential.
The reason deep learning matters here is scale and noise. A single experiment can produce expression data across tens of thousands of cells and thousands of genes simultaneously. Classical statistical tools break down at that dimensionality. The article walks through how the central dogma, DNA transcribed to RNA, RNA translated to protein, maps directly onto what sc-seq measures, and why differences in RNA abundance between cells reveal cell type, disease state, and developmental trajectory. The Human Cell Atlas Project, described by Broad Institute computational biologist Aviv Regev as a Google Maps for the human body, is the institutional frame pushing this field forward.
The article is worth reading in full because it builds the technical foundation carefully before introducing specific deep learning architectures applied to sc-seq tasks, including dimensionality reduction, batch correction, and cell type annotation. If you work in ML and have not looked at genomics data, the matrix representation alone reframes how you think about tabular biological data. If you work in biology, the framing of deep learning as infrastructure rather than novelty is the argument that demands attention.
[READ ORIGINAL →]